StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research report report published on Thursday. The brokerage issued a buy rating on the stock.
Mannatech Stock Performance
NASDAQ MTEX opened at $8.01 on Thursday. The firm has a market capitalization of $15.06 million, a P/E ratio of -6.67 and a beta of 1.18. The company has a current ratio of 1.07, a quick ratio of 0.51 and a debt-to-equity ratio of 0.09. The firm’s fifty day moving average price is $8.48 and its two-hundred day moving average price is $8.69. Mannatech has a 1 year low of $7.50 and a 1 year high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Thursday, March 28th. The company reported ($0.94) earnings per share for the quarter. Mannatech had a negative return on equity of 19.19% and a negative net margin of 1.70%. The firm had revenue of $32.69 million for the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- Business Services Stocks Investing
- MarketBeat Week in Review – 4/29 – 5/3
- How to Capture the Benefits of Dividend Increases
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
